Neurosteer has developed a solution designed for early detection and more effective treatment of a variety of neurological disorders. Its platform consists of a medical-grade wearable device and a cloud-based system that provide real-time monitoring and assessment of brain activity. The companys current focus is on delivering objective biomarkers to identify the early onset of Parkinsons disease, Alzheimers disease, dementia, and epilepsy.
Neurosteer uses an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing. Advanced algorithms then decompose the single EEG channel into over 100 individual components for real-time analysis and display on a web-based dashboard. The results are more affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, leading to improved neurological treatment and clinical trial outcomes.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Neurosteer Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Mar 10, 2020
blogs.timesofisrael.com
Neurosteer pursues wearable device to detect Alzheimer's
#Customers #Investment
Apr 10, 2019
www.israel21c.org
New monitoring tool could revolutionize brain treatment
#Customers #Investment
Sep 14, 2016
medium.com
Cracking the Code on Mobile Brain Monitoring -Nathan Intrator, Neurosteer-Full
#Expand
Nov 2, 2015
www.healtheuropa.eu
Neurosteer: introducing a novel brain activity monitor